Reduced levels of MicroRNAs 143 and 181d (mir-143 and mir-181d) in Obesity

Research output: Contribution to conferencePoster

Abstract

Obesity is a global epidemic and an increasing concern for health and wellbeing worldwide. It predisposes individuals to numerous medical comorbidities such as Type2 diabetes and cardiovascular disease. New research is uncovering the role of epigenetics in obesity . One of the potential epigenetic factors, which appear to play a regulatory role in many biological processes associated with obesity, including adipocyte differentiation and lipid metabolism, are MicroRNAs (miRNAs) . Several miRNA molecules have already been implicated in obesity and Diabetes. Our aim was to study the dysregulated expression of miR-143 and miR-181d in blood circulation and adipose tissue in a cohort of 144 obese and non obese people and assess their possible role in obesity.
Original languageEnglish
Publication statusPublished - 4 Dec 2017
EventInternational Diabetes Federation (IDF) Congress 2017 - Abudhabi, Abudhabi, United Arab Emirates
Duration: 4 Dec 20178 Dec 2017

Conference

ConferenceInternational Diabetes Federation (IDF) Congress 2017
CountryUnited Arab Emirates
CityAbudhabi
Period4/12/178/12/17

Fingerprint Dive into the research topics of 'Reduced levels of MicroRNAs 143 and 181d (mir-143 and mir-181d) in Obesity'. Together they form a unique fingerprint.

  • Cite this

    Cherian, P., Al Khairi, I., Abubaker, J., Abu-Farha, M., Alkandari, A., & Tuomilehto, J. (2017). Reduced levels of MicroRNAs 143 and 181d (mir-143 and mir-181d) in Obesity. Poster session presented at International Diabetes Federation (IDF) Congress 2017, Abudhabi, United Arab Emirates.